Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001737287-26-000002

EVP of R&D sold 35,700 shares at $1.77 ($63,189)

From the SEC's structured data for this filing

Trades in this filing

Roberts Zachary · EVP of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form −35,700 $1.77 $63,189 581,166 D
Open-market sales · 35,700 sh · avg $1.77 · $63,189

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 2 in the form Stock Option (Right to buy) +718,763 718,763 D
2026-02-02 Grant or award : show line 3 in the form Restricted Stock Unit +203,307 203,307 D
Loading xslF345X05/wk-form4_1770242855.xml…